Functional implications of a novel EA2 mutation in the P/Q-type calcium channel

Annals of Neurology

Volumn 56, Issue 2, 2004, Pages 213-220

  Spacey, Sian D ^a,d   Hildebrand, Michael E ^a   Materek, Luke A ^a   Bird, Thomas D ^b,c   Snutch, Terrance P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE;

ADULT; ARTICLE; ATAXIA; AUTOSOMAL DOMINANT DISORDER; BIOPHYSICS; CACNAIA GENE; CASE REPORT; CELL CULTURE; DRUG MECHANISM; ELECTROPHYSIOLOGY; EPISODIC ATAXIA 2 GENE; EPISODIC ATAXIA TYPE 2; FEMALE; GENE; GENE LOCATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMBRANE CURRENT; MEMBRANE POTENTIAL; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NAUSEA; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VERTIGO;

ACETAZOLAMIDE; ADULT; ANTICONVULSANTS; ATAXIA; CALCIUM CHANNELS; CELL LINE; DNA MUTATIONAL ANALYSIS; ELECTRIC STIMULATION; EMBRYO; HETERODUPLEX ANALYSIS; HISTIDINE; HUMANS; KIDNEY; LEUCINE; MEMBRANE POTENTIALS; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; PATCH-CLAMP TECHNIQUES; TIME FACTORS; TRANSFECTION;

EID: 3843077388     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20169     Document Type: Article

References (14)

1. Spacey SD. Episodic ataxia type 2. In: GeneReviews at GeneTests-GeneTests: Medical Genetics Information Resource. University of Washington, Seattle. Available at: http:// www.genetests.org.
2. Jen J, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology 2004;62:17-22.
3. Griggs RC, Moxley RT III, Lafrance RA, McQuillen J. Hereditary paroxysmal ataxia response to acetazolamide. Neurology 1978;28:1259-1264.
4. Mintz IM, Venema VJ, Swiderek KM, et al. P-type calcium channels blocked by the spider toxin omega-Aga-IVA. Nature 1992;355:827-829.
5. Jouvenceau A, Eunson LH, Spauschus A, et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 2001;8;358:801-807.
6. Guida S, Trettel F, Pagnutti S, et al. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet 2001;68:759-764.
7. 2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J Biol Chem 2002;277:6960-6966.
8. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are cause by mutations in the Ca channel gene CACNL1A4. Cell 1996;87: 543-552.
9. Zoller MJ, Smith M. Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single stranded DNA template. DNA 1984;3:479-488.
10. Hildebrand ME, McRory JE, Snutch TP, Stea A. Mammalian voltage-gated calcium channels are potently blocked by the pyrethroid insecticide allethrin. J Pharmacol Exp Ther 2004;308: 805-813.
11. Hamill OP, Marty A, Neher E, et al. Improved patch clamp techniques for high-resolution current recordings from cells and cell-free membrane patches. Pfluegers Arch 1981;391: 85-100.
12. v2.1 current density in neurons. Proc Natl Acad Sci USA 2002;99:13284-13289.
13. Wan J, Baloh RW, Jen JC. Mechanism of action of acetazolamide in treatment of episodic ataxia type 2. Neurology 2003; 60:330-331.
14. Munsch T, Pape HC. Modulation of the hyperpolarization-activated cation current of rat thalamic relay neurones by intracellular pH. J Physiol 1999;519:493-504.